influenza therapeutic landscape - isirv home · 2018. 12. 5. · cr6261 mab grp 1 ct-p27 2 mabs...

1
Flufivitide-3 HA inhibitor Radavirsen Equine Polyclonal H5 Xofluza Baloxavir TCN-032 mAb M2e TCAD Combo Pimodivir PB2 inhibitor CR6261 mAb Grp 1 CT-P27 2 mAbs VIS-410 mAb Favipiravir Flumadine (Rimantadine ) Symmetrel (Amantadine) Inavir Laninamivir (Japan only) Tamiflu oseltamivir Relenza zanamivir Rapivab peramivir GP1001 (ImmMod) PUR003 Alferon LDO INF-αn3 FLUDASE Nitazoxanide Phase 1 Phase 2 Phase 3 Market Viral Targets Host Targets Verdinexor High titer influenza immune plasma Celecoxi b Atorvastatin IVIg H1N1/H3N2 Flufenamic acid (FFA) KT07 herb mix Etilefrine Diltiazem PA Inhibitor M2 Inhibitors NAIs Influenza Therapeutic Landscape Other Inhaled IV Oral Apomivir XC221 ZSP1273

Upload: others

Post on 28-Jan-2021

0 views

Category:

Documents


0 download

TRANSCRIPT

  • Flufivitide-3

    HA inhibitor

    RadavirsenEquine

    Polyclonal H5

    Xofluza

    Baloxavir

    TCN-032

    mAb M2e

    TCAD

    Combo

    Pimodivir

    PB2 inhibitor

    CR6261

    mAb Grp 1CT-P27

    2 mAbs

    VIS-410

    mAb

    FavipiravirFlumadine

    (Rimantadine

    )

    Symmetrel

    (Amantadine)

    Inavir

    Laninamivir

    (Japan only)

    Tamiflu

    oseltamivir

    Relenza

    zanamivir

    Rapivab

    peramivir

    GP1001

    (ImmMod)PUR003 Alferon LDO

    INF-αn3

    FLUDASENitazoxanide

    Phase 1 Phase 2 Phase 3 Market

    Vir

    al T

    arge

    tsH

    ost

    Tar

    gets

    Verdinexor

    High titer

    influenza

    immune plasma

    Celecoxi

    b

    Atorvastatin

    IVIgH1N1/H3N2

    Flufenamic

    acid (FFA)KT07

    herb mix

    Etilefrine

    Diltiazem

    PA Inhibitor

    M2 Inhibitors NAIs

    Influenza Therapeutic Landscape

    Other

    Inhaled

    IV

    Oral

    Apomivir

    XC221

    ZSP1273